MMTV-cre;Ccn6 knockout mice develop tumors recapitulating human metaplastic breast carcinomas
Metaplastic breast carcinoma is an aggressive form of invasive breast cancer with histological evidence of epithelial to mesenchymal transition (EMT). However, the defining molecular events are unknown. Here we show that CCN6 (WISP3), a secreted matricellular protein of the CCN (CYR61/CTGF/NOV) fami...
Gespeichert in:
Veröffentlicht in: | Oncogene 2017-04, Vol.36 (16), p.2275-2285 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Metaplastic breast carcinoma is an aggressive form of invasive breast cancer with histological evidence of epithelial to mesenchymal transition (EMT). However, the defining molecular events are unknown. Here we show that CCN6 (WISP3), a secreted matricellular protein of the CCN (CYR61/CTGF/NOV) family, is significantly downregulated in clinical samples of human spindle cell metaplastic breast carcinoma. We generated a mouse model of mammary epithelial-specific
Ccn6
deletion by developing a floxed
Ccn6
mouse which was bred with an MMTV-Cre mouse.
Ccn6
fl/fl
;MMTV-Cre mice displayed severe defects in ductal branching and abnormal age-related involution compared to littermate controls.
Ccn6
fl/fl
;MMTV-Cre mice developed invasive high grade mammary carcinomas with
bona fide
EMT, histologically similar to human metaplastic breast carcinomas. Global gene expression profiling of
Ccn6
fl/fl
mammary carcinomas and comparison of orthologous genes with a human metaplastic carcinoma signature revealed a significant overlap of 87 genes (
P
=5 × 10
−11
). Among the shared deregulated genes between mouse and human are important regulators of epithelial morphogenesis including
Cdh1, Ck19, Cldn3
and
4, Ddr1,
and
Wnt10a
. These results document a causal role for
Ccn6
deletion in the pathogenesis of metaplastic carcinomas with histological and molecular similarities with human disease. We provide a platform to study new targets in the diagnosis and treatment of human metaplastic carcinomas, and a new disease relevant model in which to test new treatment strategies. |
---|---|
ISSN: | 0950-9232 1476-5594 |
DOI: | 10.1038/onc.2016.381 |